CorMedix Inc. (CRMD) › Cash & EquivalentsCorMedix Inc. (CRMD) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2006-07-27: $02009-12-31: $1.51M2010-12-31: $8.28M2011-12-31: $1.99M2012-12-31: $835.5K2013-12-31: $2.37M2014-12-31: $4.34M2015-12-31: $11.82M2016-12-31: $8.06M2017-12-31: $10.38M2018-12-31: $17.62M2019-12-31: $16.35M2020-12-31: $41.91M2021-12-31: $53.32M2022-12-31: $43.15M2023-12-31: $43.64M2024-12-31: $40.65M2025-12-31: $144.84M$144.84M2006-07-27Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$144.84M+256.3%2026-03-05Balance as of period end2024-12-31$40.65M-6.9%2026-03-05Balance as of period end2023-12-31$43.64M+1.1%2025-03-25Balance as of period end2022-12-31$43.15M-19.1%2024-03-12Balance as of period end2021-12-31$53.32M+27.2%2023-03-30Balance as of period end2020-12-31$41.91M+156.3%2022-03-29Balance as of period end2019-12-31$16.35M-7.2%2021-03-30Balance as of period end2018-12-31$17.62M+69.8%2020-03-16Balance as of period end2017-12-31$10.38M+28.7%2019-05-29Balance as of period end2016-12-31$8.06M-31.8%2018-03-19Balance as of period end2015-12-31$11.82M+172.3%2018-03-19Balance as of period end2014-12-31$4.34M+82.8%2017-03-16Balance as of period end2013-12-31$2.37M+184.1%2017-03-16Balance as of period end2012-12-31$835.5K-57.9%2015-03-12Balance as of period end2011-12-31$1.99M-76.0%2014-03-31Balance as of period end2010-12-31$8.28M+450.3%2014-03-04Balance as of period end2009-12-31$1.51M—2012-04-26Balance as of period end2006-07-27$0—2014-03-31Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)